Apotheca Biosciences (NASDAQ:CBDC) Stock Price Down 44.4%

Apotheca Biosciences (NASDAQ:CBDC) dropped 44.4% during mid-day trading on Thursday . The company traded as low as $0.02 and last traded at $0.02, approximately 700 shares changed hands during mid-day trading. A decline of 99% from the average daily volume of 77,643 shares. The stock had previously closed at $0.03.

The stock’s fifty day simple moving average is $0.03.

In related news, Director Steven F. Strandberg purchased 4,619 shares of Apotheca Biosciences stock in a transaction on Wednesday, July 24th. The shares were bought at an average cost of $19.79 per share, for a total transaction of $91,410.01. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Apotheca Biosciences Company Profile (NASDAQ:CBDC)

Apotheca Biosciences, Inc develops cutting-edge medical products, nutraceuticals, formulation, and delivery technologies for the healthcare and consumer care industry. The company is based in the United States.

Recommended Story: What is quantitative easing?

Receive News & Ratings for Apotheca Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apotheca Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.